| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2201995 | Neurochemistry International | 2006 | 6 Pages |
Abstract
In conclusion, the current study shows that the therapeutic window of B2 receptor inhibition extends for up to 6.5Â h after MCAo. Our data therefore suggest that inhibition of kinin B2 receptors represents a treatment strategy for ischemic stroke which may warrant clinical validation.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Benjamin Kläsner, David B. Lumenta, Didier Pruneau, Stefan Zausinger, Nikolaus Plesnila,